nodes	percent_of_prediction	percent_of_DWPC	metapath
Dextroamphetamine—Weight decreased—Auranofin—psoriatic arthritis	0.0192	0.0192	CcSEcCtD
Dextroamphetamine—Tooth disorder—Triamcinolone—psoriatic arthritis	0.0153	0.0153	CcSEcCtD
Dextroamphetamine—Angioedema—Auranofin—psoriatic arthritis	0.0135	0.0135	CcSEcCtD
Dextroamphetamine—Sudden death—Methotrexate—psoriatic arthritis	0.0128	0.0128	CcSEcCtD
Dextroamphetamine—Viral infection—Prednisolone—psoriatic arthritis	0.012	0.012	CcSEcCtD
Dextroamphetamine—Anorexia—Auranofin—psoriatic arthritis	0.0115	0.0115	CcSEcCtD
Dextroamphetamine—Dysmenorrhoea—Triamcinolone—psoriatic arthritis	0.0109	0.0109	CcSEcCtD
Dextroamphetamine—Dyspepsia—Auranofin—psoriatic arthritis	0.0106	0.0106	CcSEcCtD
Dextroamphetamine—Decreased appetite—Auranofin—psoriatic arthritis	0.0105	0.0105	CcSEcCtD
Dextroamphetamine—Constipation—Auranofin—psoriatic arthritis	0.0103	0.0103	CcSEcCtD
Dextroamphetamine—Gastrointestinal pain—Auranofin—psoriatic arthritis	0.00988	0.00988	CcSEcCtD
Dextroamphetamine—Urticaria—Auranofin—psoriatic arthritis	0.0096	0.0096	CcSEcCtD
Dextroamphetamine—Abdominal pain—Auranofin—psoriatic arthritis	0.00955	0.00955	CcSEcCtD
Dextroamphetamine—Euphoric mood—Prednisolone—psoriatic arthritis	0.00928	0.00928	CcSEcCtD
Dextroamphetamine—Viral infection—Prednisone—psoriatic arthritis	0.00869	0.00869	CcSEcCtD
Dextroamphetamine—Euphoric mood—Triamcinolone—psoriatic arthritis	0.00853	0.00853	CcSEcCtD
Dextroamphetamine—Injury—Prednisolone—psoriatic arthritis	0.00853	0.00853	CcSEcCtD
Dextroamphetamine—Euphoric mood—Methylprednisolone—psoriatic arthritis	0.00851	0.00851	CcSEcCtD
Dextroamphetamine—Diarrhoea—Auranofin—psoriatic arthritis	0.00827	0.00827	CcSEcCtD
Dextroamphetamine—Injury—Triamcinolone—psoriatic arthritis	0.00784	0.00784	CcSEcCtD
Dextroamphetamine—Injury—Methylprednisolone—psoriatic arthritis	0.00782	0.00783	CcSEcCtD
Dextroamphetamine—Euphoric mood—Dexamethasone—psoriatic arthritis	0.00774	0.00774	CcSEcCtD
Dextroamphetamine—Euphoric mood—Betamethasone—psoriatic arthritis	0.00774	0.00774	CcSEcCtD
Dextroamphetamine—Affect lability—Prednisolone—psoriatic arthritis	0.00771	0.00772	CcSEcCtD
Dextroamphetamine—Vomiting—Auranofin—psoriatic arthritis	0.00768	0.00768	CcSEcCtD
Dextroamphetamine—Speech disorder—Methotrexate—psoriatic arthritis	0.00762	0.00763	CcSEcCtD
Dextroamphetamine—Rash—Auranofin—psoriatic arthritis	0.00762	0.00762	CcSEcCtD
Dextroamphetamine—Dermatitis—Auranofin—psoriatic arthritis	0.00761	0.00761	CcSEcCtD
Dextroamphetamine—Mood swings—Prednisolone—psoriatic arthritis	0.00743	0.00743	CcSEcCtD
Dextroamphetamine—Nausea—Auranofin—psoriatic arthritis	0.00718	0.00718	CcSEcCtD
Dextroamphetamine—Injury—Betamethasone—psoriatic arthritis	0.00712	0.00712	CcSEcCtD
Dextroamphetamine—Injury—Dexamethasone—psoriatic arthritis	0.00712	0.00712	CcSEcCtD
Dextroamphetamine—Affect lability—Triamcinolone—psoriatic arthritis	0.00709	0.0071	CcSEcCtD
Dextroamphetamine—Affect lability—Methylprednisolone—psoriatic arthritis	0.00708	0.00708	CcSEcCtD
Dextroamphetamine—Psychotic disorder—Methylprednisolone—psoriatic arthritis	0.00702	0.00703	CcSEcCtD
Dextroamphetamine—Irritability—Methylprednisolone—psoriatic arthritis	0.00686	0.00687	CcSEcCtD
Dextroamphetamine—Mood swings—Triamcinolone—psoriatic arthritis	0.00683	0.00683	CcSEcCtD
Dextroamphetamine—Mood swings—Methylprednisolone—psoriatic arthritis	0.00681	0.00681	CcSEcCtD
Dextroamphetamine—Euphoric mood—Prednisone—psoriatic arthritis	0.00674	0.00674	CcSEcCtD
Dextroamphetamine—Affect lability—Dexamethasone—psoriatic arthritis	0.00644	0.00644	CcSEcCtD
Dextroamphetamine—Affect lability—Betamethasone—psoriatic arthritis	0.00644	0.00644	CcSEcCtD
Dextroamphetamine—Psychotic disorder—Dexamethasone—psoriatic arthritis	0.00639	0.00639	CcSEcCtD
Dextroamphetamine—Psychotic disorder—Betamethasone—psoriatic arthritis	0.00639	0.00639	CcSEcCtD
Dextroamphetamine—Irritability—Dexamethasone—psoriatic arthritis	0.00624	0.00624	CcSEcCtD
Dextroamphetamine—Irritability—Betamethasone—psoriatic arthritis	0.00624	0.00624	CcSEcCtD
Dextroamphetamine—Injury—Prednisone—psoriatic arthritis	0.0062	0.0062	CcSEcCtD
Dextroamphetamine—Mood swings—Dexamethasone—psoriatic arthritis	0.0062	0.0062	CcSEcCtD
Dextroamphetamine—Mood swings—Betamethasone—psoriatic arthritis	0.0062	0.0062	CcSEcCtD
Dextroamphetamine—Acute coronary syndrome—Prednisolone—psoriatic arthritis	0.00595	0.00596	CcSEcCtD
Dextroamphetamine—Myocardial infarction—Prednisolone—psoriatic arthritis	0.00592	0.00592	CcSEcCtD
Dextroamphetamine—Affect lability—Prednisone—psoriatic arthritis	0.00561	0.00561	CcSEcCtD
Dextroamphetamine—Psychotic disorder—Prednisone—psoriatic arthritis	0.00556	0.00556	CcSEcCtD
Dextroamphetamine—Acute coronary syndrome—Triamcinolone—psoriatic arthritis	0.00548	0.00548	CcSEcCtD
Dextroamphetamine—Acute coronary syndrome—Methylprednisolone—psoriatic arthritis	0.00546	0.00546	CcSEcCtD
Dextroamphetamine—Myocardial infarction—Triamcinolone—psoriatic arthritis	0.00544	0.00545	CcSEcCtD
Dextroamphetamine—Irritability—Prednisone—psoriatic arthritis	0.00544	0.00544	CcSEcCtD
Dextroamphetamine—Myocardial infarction—Methylprednisolone—psoriatic arthritis	0.00543	0.00543	CcSEcCtD
Dextroamphetamine—Mood swings—Prednisone—psoriatic arthritis	0.0054	0.0054	CcSEcCtD
Dextroamphetamine—Sweating—Methylprednisolone—psoriatic arthritis	0.00531	0.00531	CcSEcCtD
Dextroamphetamine—Weight decreased—Dexamethasone—psoriatic arthritis	0.00511	0.00512	CcSEcCtD
Dextroamphetamine—Weight decreased—Betamethasone—psoriatic arthritis	0.00511	0.00512	CcSEcCtD
Dextroamphetamine—Acute coronary syndrome—Dexamethasone—psoriatic arthritis	0.00497	0.00497	CcSEcCtD
Dextroamphetamine—Acute coronary syndrome—Betamethasone—psoriatic arthritis	0.00497	0.00497	CcSEcCtD
Dextroamphetamine—Myocardial infarction—Betamethasone—psoriatic arthritis	0.00494	0.00494	CcSEcCtD
Dextroamphetamine—Myocardial infarction—Dexamethasone—psoriatic arthritis	0.00494	0.00494	CcSEcCtD
Dextroamphetamine—Cerebrovascular accident—Methotrexate—psoriatic arthritis	0.00486	0.00486	CcSEcCtD
Dextroamphetamine—Irritability—Methotrexate—psoriatic arthritis	0.00454	0.00454	CcSEcCtD
Dextroamphetamine—Erectile dysfunction—Prednisone—psoriatic arthritis	0.00453	0.00453	CcSEcCtD
Dextroamphetamine—Mood swings—Methotrexate—psoriatic arthritis	0.00451	0.00451	CcSEcCtD
Dextroamphetamine—Weight decreased—Prednisone—psoriatic arthritis	0.00445	0.00445	CcSEcCtD
Dextroamphetamine—Depression—Prednisone—psoriatic arthritis	0.00438	0.00438	CcSEcCtD
Dextroamphetamine—Acute coronary syndrome—Prednisone—psoriatic arthritis	0.00433	0.00433	CcSEcCtD
Dextroamphetamine—Angioedema—Prednisolone—psoriatic arthritis	0.00431	0.00431	CcSEcCtD
Dextroamphetamine—Myocardial infarction—Prednisone—psoriatic arthritis	0.0043	0.0043	CcSEcCtD
Dextroamphetamine—Toxic epidermal necrolysis—Methotrexate—psoriatic arthritis	0.00429	0.00429	CcSEcCtD
Dextroamphetamine—Convulsion—Prednisolone—psoriatic arthritis	0.00409	0.00409	CcSEcCtD
Dextroamphetamine—Hypertension—Prednisolone—psoriatic arthritis	0.00408	0.00408	CcSEcCtD
Dextroamphetamine—Angioedema—Triamcinolone—psoriatic arthritis	0.00397	0.00397	CcSEcCtD
Dextroamphetamine—Angioedema—Methylprednisolone—psoriatic arthritis	0.00396	0.00396	CcSEcCtD
Dextroamphetamine—Anaphylactic shock—Prednisolone—psoriatic arthritis	0.00385	0.00385	CcSEcCtD
Dextroamphetamine—Erectile dysfunction—Methotrexate—psoriatic arthritis	0.00379	0.00379	CcSEcCtD
Dextroamphetamine—Convulsion—Triamcinolone—psoriatic arthritis	0.00376	0.00376	CcSEcCtD
Dextroamphetamine—Tachycardia—Prednisolone—psoriatic arthritis	0.00376	0.00376	CcSEcCtD
Dextroamphetamine—Photosensitivity reaction—Methotrexate—psoriatic arthritis	0.00376	0.00376	CcSEcCtD
Dextroamphetamine—Convulsion—Methylprednisolone—psoriatic arthritis	0.00375	0.00375	CcSEcCtD
Dextroamphetamine—Hypertension—Triamcinolone—psoriatic arthritis	0.00375	0.00375	CcSEcCtD
Dextroamphetamine—Hypertension—Methylprednisolone—psoriatic arthritis	0.00374	0.00374	CcSEcCtD
Dextroamphetamine—Hyperhidrosis—Prednisolone—psoriatic arthritis	0.00372	0.00373	CcSEcCtD
Dextroamphetamine—Anxiety—Methylprednisolone—psoriatic arthritis	0.00367	0.00368	CcSEcCtD
Dextroamphetamine—Depression—Methotrexate—psoriatic arthritis	0.00366	0.00366	CcSEcCtD
Dextroamphetamine—Stevens-Johnson syndrome—Methotrexate—psoriatic arthritis	0.00364	0.00364	CcSEcCtD
Dextroamphetamine—Dry mouth—Triamcinolone—psoriatic arthritis	0.00361	0.00362	CcSEcCtD
Dextroamphetamine—Angioedema—Betamethasone—psoriatic arthritis	0.0036	0.0036	CcSEcCtD
Dextroamphetamine—Angioedema—Dexamethasone—psoriatic arthritis	0.0036	0.0036	CcSEcCtD
Dextroamphetamine—Anaphylactic shock—Triamcinolone—psoriatic arthritis	0.00354	0.00354	CcSEcCtD
Dextroamphetamine—Anaphylactic shock—Methylprednisolone—psoriatic arthritis	0.00353	0.00354	CcSEcCtD
Dextroamphetamine—Infection—Triamcinolone—psoriatic arthritis	0.00352	0.00352	CcSEcCtD
Dextroamphetamine—Sweating—Methotrexate—psoriatic arthritis	0.00352	0.00352	CcSEcCtD
Dextroamphetamine—Infection—Methylprednisolone—psoriatic arthritis	0.00351	0.00351	CcSEcCtD
Dextroamphetamine—Insomnia—Prednisolone—psoriatic arthritis	0.00348	0.00349	CcSEcCtD
Dextroamphetamine—Tachycardia—Triamcinolone—psoriatic arthritis	0.00346	0.00346	CcSEcCtD
Dextroamphetamine—Tachycardia—Methylprednisolone—psoriatic arthritis	0.00345	0.00345	CcSEcCtD
Dextroamphetamine—Hyperhidrosis—Triamcinolone—psoriatic arthritis	0.00342	0.00343	CcSEcCtD
Dextroamphetamine—Hyperhidrosis—Methylprednisolone—psoriatic arthritis	0.00342	0.00342	CcSEcCtD
Dextroamphetamine—Convulsion—Betamethasone—psoriatic arthritis	0.00341	0.00341	CcSEcCtD
Dextroamphetamine—Convulsion—Dexamethasone—psoriatic arthritis	0.00341	0.00341	CcSEcCtD
Dextroamphetamine—Hypertension—Dexamethasone—psoriatic arthritis	0.0034	0.0034	CcSEcCtD
Dextroamphetamine—Hypertension—Betamethasone—psoriatic arthritis	0.0034	0.0034	CcSEcCtD
Dextroamphetamine—Anxiety—Dexamethasone—psoriatic arthritis	0.00334	0.00334	CcSEcCtD
Dextroamphetamine—Anxiety—Betamethasone—psoriatic arthritis	0.00334	0.00334	CcSEcCtD
Dextroamphetamine—Anaphylactic shock—Betamethasone—psoriatic arthritis	0.00321	0.00322	CcSEcCtD
Dextroamphetamine—Anaphylactic shock—Dexamethasone—psoriatic arthritis	0.00321	0.00322	CcSEcCtD
Dextroamphetamine—Insomnia—Triamcinolone—psoriatic arthritis	0.0032	0.00321	CcSEcCtD
Dextroamphetamine—Insomnia—Methylprednisolone—psoriatic arthritis	0.0032	0.0032	CcSEcCtD
Dextroamphetamine—Infection—Dexamethasone—psoriatic arthritis	0.00319	0.00319	CcSEcCtD
Dextroamphetamine—Infection—Betamethasone—psoriatic arthritis	0.00319	0.00319	CcSEcCtD
Dextroamphetamine—Dyspnoea—Triamcinolone—psoriatic arthritis	0.00316	0.00316	CcSEcCtD
Dextroamphetamine—Agitation—Prednisone—psoriatic arthritis	0.00315	0.00315	CcSEcCtD
Dextroamphetamine—Tachycardia—Dexamethasone—psoriatic arthritis	0.00314	0.00314	CcSEcCtD
Dextroamphetamine—Tachycardia—Betamethasone—psoriatic arthritis	0.00314	0.00314	CcSEcCtD
Dextroamphetamine—Angioedema—Prednisone—psoriatic arthritis	0.00313	0.00313	CcSEcCtD
Dextroamphetamine—Dyspepsia—Triamcinolone—psoriatic arthritis	0.00312	0.00312	CcSEcCtD
Dextroamphetamine—Erythema multiforme—Methotrexate—psoriatic arthritis	0.00311	0.00311	CcSEcCtD
Dextroamphetamine—Dyspepsia—Methylprednisolone—psoriatic arthritis	0.00311	0.00311	CcSEcCtD
Dextroamphetamine—Hyperhidrosis—Dexamethasone—psoriatic arthritis	0.00311	0.00311	CcSEcCtD
Dextroamphetamine—Hyperhidrosis—Betamethasone—psoriatic arthritis	0.00311	0.00311	CcSEcCtD
Dextroamphetamine—Anorexia—Dexamethasone—psoriatic arthritis	0.00306	0.00306	CcSEcCtD
Dextroamphetamine—Anorexia—Betamethasone—psoriatic arthritis	0.00306	0.00306	CcSEcCtD
Dextroamphetamine—Urticaria—Prednisolone—psoriatic arthritis	0.00306	0.00306	CcSEcCtD
Dextroamphetamine—Fatigue—Triamcinolone—psoriatic arthritis	0.00305	0.00306	CcSEcCtD
Dextroamphetamine—Fatigue—Methylprednisolone—psoriatic arthritis	0.00305	0.00305	CcSEcCtD
Dextroamphetamine—Convulsion—Prednisone—psoriatic arthritis	0.00297	0.00297	CcSEcCtD
Dextroamphetamine—Hypertension—Prednisone—psoriatic arthritis	0.00296	0.00296	CcSEcCtD
Dextroamphetamine—Anxiety—Prednisone—psoriatic arthritis	0.00291	0.00291	CcSEcCtD
Dextroamphetamine—Insomnia—Betamethasone—psoriatic arthritis	0.00291	0.00291	CcSEcCtD
Dextroamphetamine—Insomnia—Dexamethasone—psoriatic arthritis	0.00291	0.00291	CcSEcCtD
Dextroamphetamine—Gastrointestinal pain—Methylprednisolone—psoriatic arthritis	0.00289	0.00289	CcSEcCtD
Dextroamphetamine—Hypersensitivity—Prednisolone—psoriatic arthritis	0.00284	0.00284	CcSEcCtD
Dextroamphetamine—Dyspepsia—Betamethasone—psoriatic arthritis	0.00283	0.00283	CcSEcCtD
Dextroamphetamine—Dyspepsia—Dexamethasone—psoriatic arthritis	0.00283	0.00283	CcSEcCtD
Dextroamphetamine—Urticaria—Triamcinolone—psoriatic arthritis	0.00281	0.00282	CcSEcCtD
Dextroamphetamine—Urticaria—Methylprednisolone—psoriatic arthritis	0.00281	0.00281	CcSEcCtD
Dextroamphetamine—Body temperature increased—Triamcinolone—psoriatic arthritis	0.0028	0.0028	CcSEcCtD
Dextroamphetamine—Anaphylactic shock—Prednisone—psoriatic arthritis	0.0028	0.0028	CcSEcCtD
Dextroamphetamine—Abdominal pain—Methylprednisolone—psoriatic arthritis	0.00279	0.0028	CcSEcCtD
Dextroamphetamine—Decreased appetite—Dexamethasone—psoriatic arthritis	0.00279	0.0028	CcSEcCtD
Dextroamphetamine—Decreased appetite—Betamethasone—psoriatic arthritis	0.00279	0.0028	CcSEcCtD
Dextroamphetamine—Infection—Prednisone—psoriatic arthritis	0.00278	0.00278	CcSEcCtD
Dextroamphetamine—Gastrointestinal disorder—Betamethasone—psoriatic arthritis	0.00278	0.00278	CcSEcCtD
Dextroamphetamine—Gastrointestinal disorder—Dexamethasone—psoriatic arthritis	0.00278	0.00278	CcSEcCtD
Dextroamphetamine—Fatigue—Dexamethasone—psoriatic arthritis	0.00277	0.00277	CcSEcCtD
Dextroamphetamine—Fatigue—Betamethasone—psoriatic arthritis	0.00277	0.00277	CcSEcCtD
Dextroamphetamine—Tachycardia—Prednisone—psoriatic arthritis	0.00273	0.00273	CcSEcCtD
Dextroamphetamine—Hyperhidrosis—Prednisone—psoriatic arthritis	0.00271	0.00271	CcSEcCtD
Dextroamphetamine—Anorexia—Prednisone—psoriatic arthritis	0.00267	0.00267	CcSEcCtD
Dextroamphetamine—Gastrointestinal pain—Dexamethasone—psoriatic arthritis	0.00263	0.00263	CcSEcCtD
Dextroamphetamine—Gastrointestinal pain—Betamethasone—psoriatic arthritis	0.00263	0.00263	CcSEcCtD
Dextroamphetamine—Hypersensitivity—Triamcinolone—psoriatic arthritis	0.00261	0.00261	CcSEcCtD
Dextroamphetamine—Hypersensitivity—Methylprednisolone—psoriatic arthritis	0.0026	0.0026	CcSEcCtD
Dextroamphetamine—Urticaria—Dexamethasone—psoriatic arthritis	0.00255	0.00255	CcSEcCtD
Dextroamphetamine—Urticaria—Betamethasone—psoriatic arthritis	0.00255	0.00255	CcSEcCtD
Dextroamphetamine—Dizziness—Prednisolone—psoriatic arthritis	0.00255	0.00255	CcSEcCtD
Dextroamphetamine—Asthenia—Triamcinolone—psoriatic arthritis	0.00254	0.00254	CcSEcCtD
Dextroamphetamine—Body temperature increased—Dexamethasone—psoriatic arthritis	0.00254	0.00254	CcSEcCtD
Dextroamphetamine—Abdominal pain—Betamethasone—psoriatic arthritis	0.00254	0.00254	CcSEcCtD
Dextroamphetamine—Body temperature increased—Betamethasone—psoriatic arthritis	0.00254	0.00254	CcSEcCtD
Dextroamphetamine—Abdominal pain—Dexamethasone—psoriatic arthritis	0.00254	0.00254	CcSEcCtD
Dextroamphetamine—Asthenia—Methylprednisolone—psoriatic arthritis	0.00254	0.00254	CcSEcCtD
Dextroamphetamine—Insomnia—Prednisone—psoriatic arthritis	0.00253	0.00253	CcSEcCtD
Dextroamphetamine—Convulsion—Methotrexate—psoriatic arthritis	0.00248	0.00248	CcSEcCtD
Dextroamphetamine—Dyspepsia—Prednisone—psoriatic arthritis	0.00246	0.00246	CcSEcCtD
Dextroamphetamine—Chest pain—Methotrexate—psoriatic arthritis	0.00244	0.00244	CcSEcCtD
Dextroamphetamine—Decreased appetite—Prednisone—psoriatic arthritis	0.00243	0.00243	CcSEcCtD
Dextroamphetamine—Rash—Prednisolone—psoriatic arthritis	0.00243	0.00243	CcSEcCtD
Dextroamphetamine—Dermatitis—Prednisolone—psoriatic arthritis	0.00243	0.00243	CcSEcCtD
Dextroamphetamine—Diarrhoea—Methylprednisolone—psoriatic arthritis	0.00242	0.00242	CcSEcCtD
Dextroamphetamine—Fatigue—Prednisone—psoriatic arthritis	0.00241	0.00241	CcSEcCtD
Dextroamphetamine—Headache—Prednisolone—psoriatic arthritis	0.00241	0.00241	CcSEcCtD
Dextroamphetamine—Constipation—Prednisone—psoriatic arthritis	0.00239	0.00239	CcSEcCtD
Dextroamphetamine—Dizziness—Triamcinolone—psoriatic arthritis	0.00234	0.00234	CcSEcCtD
Dextroamphetamine—Anaphylactic shock—Methotrexate—psoriatic arthritis	0.00234	0.00234	CcSEcCtD
Dextroamphetamine—Dizziness—Methylprednisolone—psoriatic arthritis	0.00234	0.00234	CcSEcCtD
Dextroamphetamine—Infection—Methotrexate—psoriatic arthritis	0.00232	0.00232	CcSEcCtD
Dextroamphetamine—Asthenia—Betamethasone—psoriatic arthritis	0.00231	0.00231	CcSEcCtD
Dextroamphetamine—Asthenia—Dexamethasone—psoriatic arthritis	0.00231	0.00231	CcSEcCtD
Dextroamphetamine—Gastrointestinal pain—Prednisone—psoriatic arthritis	0.00229	0.00229	CcSEcCtD
Dextroamphetamine—Nausea—Prednisolone—psoriatic arthritis	0.00229	0.00229	CcSEcCtD
Dextroamphetamine—Hyperhidrosis—Methotrexate—psoriatic arthritis	0.00226	0.00226	CcSEcCtD
Dextroamphetamine—Vomiting—Triamcinolone—psoriatic arthritis	0.00225	0.00225	CcSEcCtD
Dextroamphetamine—Vomiting—Methylprednisolone—psoriatic arthritis	0.00225	0.00225	CcSEcCtD
Dextroamphetamine—Rash—Triamcinolone—psoriatic arthritis	0.00223	0.00223	CcSEcCtD
Dextroamphetamine—Dermatitis—Triamcinolone—psoriatic arthritis	0.00223	0.00223	CcSEcCtD
Dextroamphetamine—Anorexia—Methotrexate—psoriatic arthritis	0.00223	0.00223	CcSEcCtD
Dextroamphetamine—Rash—Methylprednisolone—psoriatic arthritis	0.00223	0.00223	CcSEcCtD
Dextroamphetamine—Dermatitis—Methylprednisolone—psoriatic arthritis	0.00223	0.00223	CcSEcCtD
Dextroamphetamine—Urticaria—Prednisone—psoriatic arthritis	0.00222	0.00222	CcSEcCtD
Dextroamphetamine—Headache—Triamcinolone—psoriatic arthritis	0.00222	0.00222	CcSEcCtD
Dextroamphetamine—Headache—Methylprednisolone—psoriatic arthritis	0.00221	0.00221	CcSEcCtD
Dextroamphetamine—Body temperature increased—Prednisone—psoriatic arthritis	0.00221	0.00221	CcSEcCtD
Dextroamphetamine—Abdominal pain—Prednisone—psoriatic arthritis	0.00221	0.00221	CcSEcCtD
Dextroamphetamine—Diarrhoea—Betamethasone—psoriatic arthritis	0.0022	0.0022	CcSEcCtD
Dextroamphetamine—Diarrhoea—Dexamethasone—psoriatic arthritis	0.0022	0.0022	CcSEcCtD
Dextroamphetamine—Dizziness—Betamethasone—psoriatic arthritis	0.00213	0.00213	CcSEcCtD
Dextroamphetamine—Dizziness—Dexamethasone—psoriatic arthritis	0.00213	0.00213	CcSEcCtD
Dextroamphetamine—Insomnia—Methotrexate—psoriatic arthritis	0.00212	0.00212	CcSEcCtD
Dextroamphetamine—Nausea—Triamcinolone—psoriatic arthritis	0.0021	0.0021	CcSEcCtD
Dextroamphetamine—Nausea—Methylprednisolone—psoriatic arthritis	0.0021	0.0021	CcSEcCtD
Dextroamphetamine—Dyspnoea—Methotrexate—psoriatic arthritis	0.00209	0.00209	CcSEcCtD
Dextroamphetamine—Somnolence—Methotrexate—psoriatic arthritis	0.00208	0.00208	CcSEcCtD
Dextroamphetamine—Hypersensitivity—Prednisone—psoriatic arthritis	0.00206	0.00206	CcSEcCtD
Dextroamphetamine—Dyspepsia—Methotrexate—psoriatic arthritis	0.00206	0.00206	CcSEcCtD
Dextroamphetamine—Vomiting—Betamethasone—psoriatic arthritis	0.00204	0.00204	CcSEcCtD
Dextroamphetamine—Vomiting—Dexamethasone—psoriatic arthritis	0.00204	0.00204	CcSEcCtD
Dextroamphetamine—Decreased appetite—Methotrexate—psoriatic arthritis	0.00203	0.00203	CcSEcCtD
Dextroamphetamine—Rash—Dexamethasone—psoriatic arthritis	0.00203	0.00203	CcSEcCtD
Dextroamphetamine—Rash—Betamethasone—psoriatic arthritis	0.00203	0.00203	CcSEcCtD
Dextroamphetamine—Dermatitis—Dexamethasone—psoriatic arthritis	0.00202	0.00203	CcSEcCtD
Dextroamphetamine—Dermatitis—Betamethasone—psoriatic arthritis	0.00202	0.00203	CcSEcCtD
Dextroamphetamine—Gastrointestinal disorder—Methotrexate—psoriatic arthritis	0.00202	0.00202	CcSEcCtD
Dextroamphetamine—Fatigue—Methotrexate—psoriatic arthritis	0.00202	0.00202	CcSEcCtD
Dextroamphetamine—Headache—Dexamethasone—psoriatic arthritis	0.00201	0.00201	CcSEcCtD
Dextroamphetamine—Headache—Betamethasone—psoriatic arthritis	0.00201	0.00201	CcSEcCtD
Dextroamphetamine—Asthenia—Prednisone—psoriatic arthritis	0.00201	0.00201	CcSEcCtD
Dextroamphetamine—Diarrhoea—Prednisone—psoriatic arthritis	0.00192	0.00192	CcSEcCtD
Dextroamphetamine—Gastrointestinal pain—Methotrexate—psoriatic arthritis	0.00191	0.00191	CcSEcCtD
Dextroamphetamine—Nausea—Betamethasone—psoriatic arthritis	0.00191	0.00191	CcSEcCtD
Dextroamphetamine—Nausea—Dexamethasone—psoriatic arthritis	0.00191	0.00191	CcSEcCtD
Dextroamphetamine—Urticaria—Methotrexate—psoriatic arthritis	0.00186	0.00186	CcSEcCtD
Dextroamphetamine—Dizziness—Prednisone—psoriatic arthritis	0.00185	0.00185	CcSEcCtD
Dextroamphetamine—Abdominal pain—Methotrexate—psoriatic arthritis	0.00185	0.00185	CcSEcCtD
Dextroamphetamine—Body temperature increased—Methotrexate—psoriatic arthritis	0.00185	0.00185	CcSEcCtD
Dextroamphetamine—Vomiting—Prednisone—psoriatic arthritis	0.00178	0.00178	CcSEcCtD
Dextroamphetamine—Rash—Prednisone—psoriatic arthritis	0.00177	0.00177	CcSEcCtD
Dextroamphetamine—Dermatitis—Prednisone—psoriatic arthritis	0.00176	0.00176	CcSEcCtD
Dextroamphetamine—Headache—Prednisone—psoriatic arthritis	0.00175	0.00175	CcSEcCtD
Dextroamphetamine—Hypersensitivity—Methotrexate—psoriatic arthritis	0.00172	0.00172	CcSEcCtD
Dextroamphetamine—Asthenia—Methotrexate—psoriatic arthritis	0.00168	0.00168	CcSEcCtD
Dextroamphetamine—Nausea—Prednisone—psoriatic arthritis	0.00166	0.00166	CcSEcCtD
Dextroamphetamine—Diarrhoea—Methotrexate—psoriatic arthritis	0.0016	0.0016	CcSEcCtD
Dextroamphetamine—Dizziness—Methotrexate—psoriatic arthritis	0.00155	0.00155	CcSEcCtD
Dextroamphetamine—Vomiting—Methotrexate—psoriatic arthritis	0.00149	0.00149	CcSEcCtD
Dextroamphetamine—Rash—Methotrexate—psoriatic arthritis	0.00148	0.00148	CcSEcCtD
Dextroamphetamine—Dermatitis—Methotrexate—psoriatic arthritis	0.00147	0.00147	CcSEcCtD
Dextroamphetamine—Headache—Methotrexate—psoriatic arthritis	0.00147	0.00147	CcSEcCtD
Dextroamphetamine—Nausea—Methotrexate—psoriatic arthritis	0.00139	0.00139	CcSEcCtD
Dextroamphetamine—Pseudoephedrine—TNF—psoriatic arthritis	0.000245	1	CrCbGaD
